Vastarel MR (Trimetazidine dihydrochloride) 35mg Tablets

Composition:

• Active ingredient: Trimetazidine dihydrochloride 35mg

Dosage:

• The usual recommended dosage of Vastarel MR (Trimetazidine dihydrochloride) 35mg tablet is one tablet taken orally twice daily, preferably with meals.

Indications:

• Vastarel MR (Trimetazidine dihydrochloride) 35mg tablet is indicated for the treatment of angina pectoris and symptoms of vertigo and tinnitus of vascular origin.
• It is also used as an adjunct therapy in the treatment of stable angina pectoris in patients who are inadequately controlled by or intolerant to first-line antianginal therapies.

Please note that this information is for reference purposes only and should be used in consultation with a healthcare professional.